Pegcetacoplan Clinical Trial (Phase 3) Results Published
Posted on
A recent article in the prestigious journal ′”New England Journal of Medicine” published the findings of the phase 3 study of a C3 inhibitor (pegcetacoplan or APL2), intended to be […]
Read more About Pegcetacoplan Clinical Trial (Phase 3) Results Published